Emcure Pharmaceuticals consolidated net profit rises 35.50% in the December 2024 quarter

Explore Business Standard
Associate Sponsors

Sales rise 17.69% to Rs 1962.63 crore
Net profit of Emcure Pharmaceuticals rose 35.50% to Rs 153.72 crore in the quarter ended December 2024 as against Rs 113.45 crore during the previous quarter ended December 2023. Sales rose 17.69% to Rs 1962.63 crore in the quarter ended December 2024 as against Rs 1667.64 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales1962.631667.64 18 OPM %18.0718.41 -PBDT326.73262.01 25 PBT229.92177.62 29 NP153.72113.45 35Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Feb 06 2025 | 5:39 PM IST